NASDAQ
Aura Biosciences, Inc. (AURA) has a free cash flow growth of -45.29% as of Friday, May 29, 2026. This represents a 1287.52% decrease compared to its 12-month average of 3.81%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.